Insulin aspart, recombinant Subcutaneous and SMOFlipid
Determining the interaction of Insulin aspart, recombinant Subcutaneous and SMOFlipid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: fat emulsion
Brand name: SMOFlipid, Clinolipid, Intralipid, Nutrilipid, Omegaven
Synonyms: Smoflipid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-SMZ-TMP Pediatric
- Insulin aspart, recombinant Subcutaneous-Sodium Acetate
- Insulin aspart, recombinant Subcutaneous-Sodium bicarbonate
- Insulin aspart, recombinant Subcutaneous-Sodium Bicarbonate Infant Injection
- Insulin aspart, recombinant Subcutaneous-Sodium Bicarbonate Injection
- Insulin aspart, recombinant Subcutaneous-Sodium bicarbonate Oral, Intravenous, Subcutaneous
- SMOFlipid-Insulin degludec
- SMOFlipid-Insulin Degludec (U-100) Prefilled Pens
- SMOFlipid-Insulin Degludec (U-100) Vials
- SMOFlipid-Insulin Degludec (U-200) Prefilled Pens
- SMOFlipid-Insulin degludec and liraglutide
- SMOFlipid-Insulin degludec and liraglutide Subcutaneous